stockportfolio.pro
TransMedics Group, Inc. Net Income 2018–2025
TransMedics Group, Inc. (TMDX) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $190.29M | 31.4% | +436.6% |
| FY 2024 | $35.46M | 8.0% | +241.7% |
| FY 2023 | $-25.03M | -10.4% | +30.9% |
| FY 2022 | $-36.23M | -38.8% | +18.1% |
| FY 2021 | $-44.22M | -146.1% | -53.8% |
| FY 2020 | $-28.75M | -112.1% | +14.3% |
| FY 2019 | $-33.55M | -142.1% | -41.2% |
| FY 2018 | $-23.76M | -182.5% | — |
Source: TransMedics Group, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for TransMedics Group, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTransMedics Group, Inc. — frequently asked questions
What is TransMedics Group, Inc.'s net income?
TransMedics Group, Inc. (TMDX) reported net income of $190.29M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from TransMedics Group, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.